Aravive logo
Aravive ARAV

Quartalsbericht 2023-Q3
hinzugefügt 09.11.2023

report update icon

Aravive Langfristiger Schuldenstrom 2011-2026 | ARAV

Langfristiger Schuldenstrom Jährlich Aravive

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
2.2 M 2.3 M 2.09 M 2.39 M - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
2.39 M 2.09 M 2.24 M

Langfristiger Schuldenstrom anderer Aktien in der Pharmaeinzelhändler

Name Langfristiger Schuldenstrom Preis % 24h Marktkapitalisierung Land
FSD Pharma FSD Pharma
HUGE
103 K - 5743.5 % $ 69.7 M canadaCanada
MorphoSys AG MorphoSys AG
MOR
3.63 M - 2.43 % $ 254 M germanyGermany
Happiness Biotech Group Limited Happiness Biotech Group Limited
HAPP
102 K - 1.35 % $ 17.8 M chinaChina
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
7.93 M $ 16.88 -2.43 % $ 789 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
181 K - -10.17 % $ 12.2 K usaUSA
Compugen Ltd. Compugen Ltd.
CGEN
768 K $ 2.79 -8.09 % $ 261 M israelIsrael
Coherus BioSciences Coherus BioSciences
CHRS
1.83 M $ 1.6 -2.15 % $ 187 M usaUSA
I-Mab I-Mab
IMAB
8.06 M - - $ 866 M chinaChina
AstraZeneca PLC AstraZeneca PLC
AZN
382 M - - $ 96.9 B britainBritain
Arcturus Therapeutics Holdings Arcturus Therapeutics Holdings
ARCT
4.21 M $ 7.56 -3.45 % $ 207 M israelIsrael
Athira Pharma Athira Pharma
ATHA
465 K - - $ 269 M usaUSA
BiondVax Pharmaceuticals Ltd. BiondVax Pharmaceuticals Ltd.
BVXV
773 K - 0.74 % $ 768 M israelIsrael
Galera Therapeutics Galera Therapeutics
GRTX
133 K - -32.59 % $ 7.61 M usaUSA
Esperion Therapeutics Esperion Therapeutics
ESPR
2.1 M $ 3.13 0.32 % $ 651 M usaUSA
Exelixis Exelixis
EXEL
27.9 M $ 50.41 -1.36 % $ 13.7 B usaUSA
Fortress Biotech Fortress Biotech
FBIO
2.13 M $ 2.43 5.65 % $ 67.8 M usaUSA
Forte Biosciences Forte Biosciences
FBRX
416 K $ 23.1 -3.57 % $ 299 M usaUSA
Fennec Pharmaceuticals Fennec Pharmaceuticals
FENC
2 K $ 9.76 5.63 % $ 279 M usaUSA
AbCellera Biologics AbCellera Biologics
ABCL
5.82 M $ 4.09 -7.05 % $ 1.22 B canadaCanada
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
4.56 M $ 1.59 - $ 423 M britainBritain
BioNTech SE BioNTech SE
BNTX
45 M $ 89.16 -3.08 % $ 21.5 B germanyGermany
Galectin Therapeutics Galectin Therapeutics
GALT
22 K $ 2.22 -5.74 % $ 142 M usaUSA
Gilead Sciences Gilead Sciences
GILD
102 M $ 130.07 -1.51 % $ 162 B usaUSA
Genmab A/S Genmab A/S
GMAB
26 M $ 26.8 -0.37 % $ 1.73 B danmarkDanmark
Advaxis Advaxis
ADXS
166 K - -9.65 % $ 45.9 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
56 K $ 3.41 -2.25 % $ 5.61 M israelIsrael
Aeterna Zentaris Aeterna Zentaris
AEZS
215 K - 5.93 % $ 314 M canadaCanada
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
625 K - - $ 1.01 B usaUSA
CureVac N.V. CureVac N.V.
CVAC
3.47 M - - $ 867 M germanyGermany
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.27 M - - $ 26.5 M usaUSA
Grifols, S.A. Grifols, S.A.
GRFS
117 M $ 7.74 -0.64 % $ 5.26 B spainSpain
AIkido Pharma AIkido Pharma
AIKI
554 K - 1.93 % $ 17.4 M usaUSA
Eton Pharmaceuticals Eton Pharmaceuticals
ETON
65 K $ 29.69 -0.92 % $ 799 M usaUSA
Aptose Biosciences Aptose Biosciences
APTO
193 K - -45.71 % $ 1.2 M canadaCanada
Aptinyx Aptinyx
APTX
337 K - -39.0 % $ 4.57 M usaUSA
Akouos Akouos
AKUS
671 K - 0.23 % $ 488 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
3.08 M - -0.23 % $ 916 M usaUSA
AlloVir AlloVir
ALVR
316 K - 4.14 % $ 49.1 M usaUSA
Allakos Allakos
ALLK
3.25 M - - $ 28.6 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
294 K $ 21.51 -0.3 % $ 2.74 B usaUSA
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
317 K - 3.16 % $ 1.9 M usaUSA